Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Samsung Bioepis collaborates to make inroads into original drugs

August 21, 2017 Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical

Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
News
shutterstock_87495637

New study debunks hypothesis that antidepressants are ineffective

August 21, 2017 Research and Development, Sales and Marketing SSRIs, anti-depressants, citalopram, life sciences, medicine, paroextine, pharma, pharmaceuticals

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …
News
aedes_aegypti_mosquito

Novartis begins ‘next-generation’ malaria treatment trial

August 21, 2017 Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical

Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

A lot has happened in the world this week, but the pharma industry still found itself on the frontlines of …
News
heart-2338154_960_720

Where will the next cardiovascular breakthrough come from?

August 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical

British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …
Feature
cancer-cell

Independent research may change the immunotherapy game

August 17, 2017 Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
News
novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017 Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …
News
microscope-275984_960_720

Cancer Research UK and NU agree three-year research Astex Pharma deal

August 17, 2017 Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
News
shutterstock

New personalised molecular blood test could shake up cancer treatment

August 16, 2017 Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …
News
old-peoples-home-524234_960_720

Massive increase in UK care home places needed by 2025, report finds

August 16, 2017 Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …
News
opdivo_1_1

BMS left red-faced as Opdivo+Yervoy fails to beat rival Pfizer drug in kidney cancer

August 16, 2017 Research and Development BMS, Kidney cancer, Yervoy, life sciences, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …
News
baby-1151345_960_720

Less sleep in children linked to increased risk of diabetes

August 16, 2017 Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …
News
heart_patch

Mending broken hearts with an injectable patch

August 16, 2017 Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …
News
doug_langa

Novo Nordisk reshuffles Executive Management team with two major additions

August 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment, life sciences, medicine, pharma, pharmaceutical

This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …
Appointment
regeneron

Regeneron abandons respiratory syncytial virus therapy after late-stage failure

August 15, 2017 Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026